Global Chondroitin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Chondroitin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.

According to APO Research, The global Chondroitin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Chondroitin include SANXIN, Focus Chem, GGI, Guanglong Biochem, Hengjie Bio-Pharmaceuticals, Huiwen, ISBA, Jiaixng Hengjie and Meitek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chondroitin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Chondroitin, also provides the sales of main regions and countries. Of the upcoming market potential for Chondroitin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chondroitin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Chondroitin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Chondroitin sales, projected growth trends, production technology, application and end-user industry.

Chondroitin segment by Company

SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
Chondroitin segment by Type

Food Grade
Pharmaceutical Grade
Chondroitin segment by Application

Pharmacy
Health Products
Chondroitin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chondroitin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chondroitin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chondroitin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chondroitin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chondroitin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chondroitin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Chondroitin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Chondroitin Market Size, 2019 VS 2023 VS 2030
1.3 Global Chondroitin Market Size Estimates and Forecasts (2019-2030)
1.4 Global Chondroitin Sales Estimates and Forecasts (2019-2030)
1.5 Global Chondroitin Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Chondroitin Market Dynamics
2.1 Chondroitin Industry Trends
2.2 Chondroitin Industry Drivers
2.3 Chondroitin Industry Opportunities and Challenges
2.4 Chondroitin Industry Restraints
3 Chondroitin Market by Manufacturers
3.1 Global Chondroitin Revenue by Manufacturers (2019-2024)
3.2 Global Chondroitin Sales by Manufacturers (2019-2024)
3.3 Global Chondroitin Average Sales Price by Manufacturers (2019-2024)
3.4 Global Chondroitin Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Chondroitin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Chondroitin Manufacturers, Product Type & Application
3.7 Global Chondroitin Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Chondroitin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Chondroitin Players Market Share by Revenue in 2023
3.8.3 2023 Chondroitin Tier 1, Tier 2, and Tier 3
4 Chondroitin Market by Type
4.1 Chondroitin Type Introduction
4.1.1 Food Grade
4.1.2 Pharmaceutical Grade
4.2 Global Chondroitin Sales by Type
4.2.1 Global Chondroitin Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Chondroitin Sales by Type (2019-2030)
4.2.3 Global Chondroitin Sales Market Share by Type (2019-2030)
4.3 Global Chondroitin Revenue by Type
4.3.1 Global Chondroitin Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Chondroitin Revenue by Type (2019-2030)
4.3.3 Global Chondroitin Revenue Market Share by Type (2019-2030)
5 Chondroitin Market by Application
5.1 Chondroitin Application Introduction
5.1.1 Pharmacy
5.1.2 Health Products
5.2 Global Chondroitin Sales by Application
5.2.1 Global Chondroitin Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Chondroitin Sales by Application (2019-2030)
5.2.3 Global Chondroitin Sales Market Share by Application (2019-2030)
5.3 Global Chondroitin Revenue by Application
5.3.1 Global Chondroitin Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Chondroitin Revenue by Application (2019-2030)
5.3.3 Global Chondroitin Revenue Market Share by Application (2019-2030)
6 Global Chondroitin Sales by Region
6.1 Global Chondroitin Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Chondroitin Sales by Region (2019-2030)
6.2.1 Global Chondroitin Sales by Region (2019-2024)
6.2.2 Global Chondroitin Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Chondroitin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Chondroitin Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Chondroitin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Chondroitin Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Chondroitin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Chondroitin Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Chondroitin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Chondroitin Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Chondroitin Revenue by Region
7.1 Global Chondroitin Revenue by Region
7.1.1 Global Chondroitin Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Chondroitin Revenue by Region (2019-2024)
7.1.3 Global Chondroitin Revenue by Region (2025-2030)
7.1.4 Global Chondroitin Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Chondroitin Revenue (2019-2030)
7.2.2 North America Chondroitin Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Chondroitin Revenue (2019-2030)
7.3.2 Europe Chondroitin Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Chondroitin Revenue (2019-2030)
7.4.2 Asia-Pacific Chondroitin Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Chondroitin Revenue (2019-2030)
7.5.2 LAMEA Chondroitin Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 SANXIN
8.1.1 SANXIN Comapny Information
8.1.2 SANXIN Business Overview
8.1.3 SANXIN Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 SANXIN Chondroitin Product Portfolio
8.1.5 SANXIN Recent Developments
8.2 Focus Chem
8.2.1 Focus Chem Comapny Information
8.2.2 Focus Chem Business Overview
8.2.3 Focus Chem Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Focus Chem Chondroitin Product Portfolio
8.2.5 Focus Chem Recent Developments
8.3 GGI
8.3.1 GGI Comapny Information
8.3.2 GGI Business Overview
8.3.3 GGI Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 GGI Chondroitin Product Portfolio
8.3.5 GGI Recent Developments
8.4 Guanglong Biochem
8.4.1 Guanglong Biochem Comapny Information
8.4.2 Guanglong Biochem Business Overview
8.4.3 Guanglong Biochem Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Guanglong Biochem Chondroitin Product Portfolio
8.4.5 Guanglong Biochem Recent Developments
8.5 Hengjie Bio-Pharmaceuticals
8.5.1 Hengjie Bio-Pharmaceuticals Comapny Information
8.5.2 Hengjie Bio-Pharmaceuticals Business Overview
8.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Product Portfolio
8.5.5 Hengjie Bio-Pharmaceuticals Recent Developments
8.6 Huiwen
8.6.1 Huiwen Comapny Information
8.6.2 Huiwen Business Overview
8.6.3 Huiwen Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Huiwen Chondroitin Product Portfolio
8.6.5 Huiwen Recent Developments
8.7 ISBA
8.7.1 ISBA Comapny Information
8.7.2 ISBA Business Overview
8.7.3 ISBA Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 ISBA Chondroitin Product Portfolio
8.7.5 ISBA Recent Developments
8.8 Jiaixng Hengjie
8.8.1 Jiaixng Hengjie Comapny Information
8.8.2 Jiaixng Hengjie Business Overview
8.8.3 Jiaixng Hengjie Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Jiaixng Hengjie Chondroitin Product Portfolio
8.8.5 Jiaixng Hengjie Recent Developments
8.9 Meitek
8.9.1 Meitek Comapny Information
8.9.2 Meitek Business Overview
8.9.3 Meitek Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Meitek Chondroitin Product Portfolio
8.9.5 Meitek Recent Developments
8.10 Nippon Zoki
8.10.1 Nippon Zoki Comapny Information
8.10.2 Nippon Zoki Business Overview
8.10.3 Nippon Zoki Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Nippon Zoki Chondroitin Product Portfolio
8.10.5 Nippon Zoki Recent Developments
8.11 Pacific Rainbow
8.11.1 Pacific Rainbow Comapny Information
8.11.2 Pacific Rainbow Business Overview
8.11.3 Pacific Rainbow Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Pacific Rainbow Chondroitin Product Portfolio
8.11.5 Pacific Rainbow Recent Developments
8.12 Qingdao Green-Extract
8.12.1 Qingdao Green-Extract Comapny Information
8.12.2 Qingdao Green-Extract Business Overview
8.12.3 Qingdao Green-Extract Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Qingdao Green-Extract Chondroitin Product Portfolio
8.12.5 Qingdao Green-Extract Recent Developments
8.13 QJBCHINA
8.13.1 QJBCHINA Comapny Information
8.13.2 QJBCHINA Business Overview
8.13.3 QJBCHINA Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 QJBCHINA Chondroitin Product Portfolio
8.13.5 QJBCHINA Recent Developments
8.14 Runxin Biotechnology
8.14.1 Runxin Biotechnology Comapny Information
8.14.2 Runxin Biotechnology Business Overview
8.14.3 Runxin Biotechnology Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Runxin Biotechnology Chondroitin Product Portfolio
8.14.5 Runxin Biotechnology Recent Developments
8.15 SANXIN GROUP
8.15.1 SANXIN GROUP Comapny Information
8.15.2 SANXIN GROUP Business Overview
8.15.3 SANXIN GROUP Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 SANXIN GROUP Chondroitin Product Portfolio
8.15.5 SANXIN GROUP Recent Developments
8.16 Shandong Dongcheng
8.16.1 Shandong Dongcheng Comapny Information
8.16.2 Shandong Dongcheng Business Overview
8.16.3 Shandong Dongcheng Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Shandong Dongcheng Chondroitin Product Portfolio
8.16.5 Shandong Dongcheng Recent Developments
8.17 Sioux Pharm
8.17.1 Sioux Pharm Comapny Information
8.17.2 Sioux Pharm Business Overview
8.17.3 Sioux Pharm Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 Sioux Pharm Chondroitin Product Portfolio
8.17.5 Sioux Pharm Recent Developments
8.18 Summit Nutritionals
8.18.1 Summit Nutritionals Comapny Information
8.18.2 Summit Nutritionals Business Overview
8.18.3 Summit Nutritionals Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Summit Nutritionals Chondroitin Product Portfolio
8.18.5 Summit Nutritionals Recent Developments
8.19 TSI Group
8.19.1 TSI Group Comapny Information
8.19.2 TSI Group Business Overview
8.19.3 TSI Group Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 TSI Group Chondroitin Product Portfolio
8.19.5 TSI Group Recent Developments
8.20 WanTuMing Biological
8.20.1 WanTuMing Biological Comapny Information
8.20.2 WanTuMing Biological Business Overview
8.20.3 WanTuMing Biological Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.20.4 WanTuMing Biological Chondroitin Product Portfolio
8.20.5 WanTuMing Biological Recent Developments
8.21 Yantai Dongcheng
8.21.1 Yantai Dongcheng Comapny Information
8.21.2 Yantai Dongcheng Business Overview
8.21.3 Yantai Dongcheng Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.21.4 Yantai Dongcheng Chondroitin Product Portfolio
8.21.5 Yantai Dongcheng Recent Developments
8.22 YBCC
8.22.1 YBCC Comapny Information
8.22.2 YBCC Business Overview
8.22.3 YBCC Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.22.4 YBCC Chondroitin Product Portfolio
8.22.5 YBCC Recent Developments
8.23 Yibao Group
8.23.1 Yibao Group Comapny Information
8.23.2 Yibao Group Business Overview
8.23.3 Yibao Group Chondroitin Sales, Price, Revenue and Gross Margin (2019-2024)
8.23.4 Yibao Group Chondroitin Product Portfolio
8.23.5 Yibao Group Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Chondroitin Value Chain Analysis
9.1.1 Chondroitin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Chondroitin Production Mode & Process
9.2 Chondroitin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Chondroitin Distributors
9.2.3 Chondroitin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings